Cargando…
Structural Modeling Insights into Human VKORC1 Phenotypes
Vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1) catalyses the reduction of vitamin K and its 2,3-epoxide essential to sustain γ-carboxylation of vitamin K-dependent proteins. Two different phenotypes are associated with mutations in human VKORC1. The majority of mutations cause resistance...
Autores principales: | Czogalla, Katrin J., Watzka, Matthias, Oldenburg, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555152/ https://www.ncbi.nlm.nih.gov/pubmed/26287237 http://dx.doi.org/10.3390/nu7085313 |
Ejemplares similares
-
VKORC1 and VKORC1L1: Why do Vertebrates Have Two Vitamin K 2,3-Epoxide Reductases?
por: Oldenburg, Johannes, et al.
Publicado: (2015) -
VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation
por: Marinova, Milka, et al.
Publicado: (2012) -
The Role of GRP and MGP in the Development of Non-Hemorrhagic VKCFD1 Phenotypes
por: Ghosh, Suvoshree, et al.
Publicado: (2022) -
Vitamin K Epoxide Reductase Complex Subunit 1-Like 1 (VKORC1L1) Inhibition Induces a Proliferative and Pro-inflammatory Vascular Smooth Muscle Cell Phenotype
por: Aksoy, Adem, et al.
Publicado: (2021) -
New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) – The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations()
por: Matagrin, Benjamin, et al.
Publicado: (2013)